Cromolyn sodium 10 MG/ML Inhalation Solution — RxCUI 831246
RxNorm drug concept · Semantic clinical drug
RxCUI 831246
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI831246
Official nameCromolyn sodium 10 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascromolyn sodium 20 MG per 2 ML Inhalation Solution; cromolyn sodium 20 MG in 2 ML Inhalation Solution
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)754 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cromolyn Oral Inhalation: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No — and this is really important to understand. Cromolyn sodium is a preventive medicine only. It does not open your airways once they've tightened up. You should always have a se...
- Will this inhaler stop an asthma attack if I'm already having one?
- It can take several weeks of regular use before you feel the full benefit — though some people notice improvement sooner. The key is consistency. Taking it at the same times every...
- How long does it take before I notice it working?
🕸️ Concept Web — How Cromolyn sodium 10 MG/ML Inhalation Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cromolyn sodium 10 MG/ML Inhalation Solution
RxCUI 831246 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Cromolyn
42612IN -
Cromolyn sodium
3538PIN
-
Cromolyn
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cromolyn Inhalation Solution
2108316SCDF -
Cromolyn sodium Inhalation Solution
2649052SCDFP -
Cromolyn Inhalant Product
1155844SCDG -
Cromolyn sodium Inhalant Product
2659367SCDGP -
Inhalation Solution
346161DF -
Inhalant Product
1151123DFG
-
Cromolyn Inhalation Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cromolyn sodium 10 MG/ML
831245SCDC
-
Cromolyn sodium 10 MG/ML
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cromolyn sodium 10 MG/ML
SCDC · 831245 -
Cromolyn Inhalation Solution
SCDF · 2108316 -
Cromolyn sodium Inhalation Solution
SCDFP · 2649052 -
Cromolyn Inhalant Product
SCDG · 1155844 -
Cromolyn sodium Inhalant Product
SCDGP · 2659367
📦 FDA Products & Package NDCs
3 products · 4 package NDCs
4 package NDCs map to RxCUI 831246 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00172-6406-49 | 12 POUCH in 1 CARTON (0172-6406-49) / 5 VIAL, SINGLE-DOSE i... | Cromolyn Sodium | Teva Pharmaceuticals USA, Inc. | 2000-01-18 |
| 42571-0350-09 | 5 CARTON in 1 CARTON (42571-350-09) / 12 AMPULE in 1 CARTON... | Cromolyn Sodium | Micro Labs Limited | 2022-06-01 |
| 42571-0350-50 | 10 CARTON in 1 CARTON (42571-350-50) / 12 AMPULE in 1 CARTO... | Cromolyn Sodium | Micro Labs Limited | 2022-06-01 |
| 76204-0028-60 | 2 POUCH in 1 CARTON (76204-028-60) / 30 AMPULE in 1 POUCH (... | Cromolyn Sodium Inhalation Solution | Ritedose Pharmaceuticals, LLC | 2021-12-01 |
Observed labelers:
Micro Labs Limited (2) ·
Ritedose Pharmaceuticals, LLC (1) ·
Teva Pharmaceuticals USA, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7631 | Cromolyn sodium noncomp unit | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.